Cannabinoids and the immune system: Potential for the treatment of inflammatory diseases?
- 30 September 2005
- journal article
- review article
- Published by Elsevier BV in Journal of Neuroimmunology
- Vol. 166 (1-2), 3-18
- https://doi.org/10.1016/j.jneuroim.2005.04.023
Abstract
No abstract availableKeywords
This publication has 171 references indexed in Scilit:
- The effect of WIN 55,212-2, a cannabinoid agonist, on tactile allodynia in diabetic ratsNeuroscience Letters, 2004
- Cannabinoid receptor-independent suppression of the superoxide generation of human neutrophils (PMN) by CP55 940, but not by anandamideLife Sciences, 2004
- Autocrine and Paracrine Regulation of Lymphocyte CB2 Receptor Expression by TGF-βBiochemical and Biophysical Research Communications, 2002
- Δ9-tetrahydrocannabinol (THC) modulates IL-1 bioactivity in human monocyte/macrophage cell linesLife Sciences, 1994
- Association of Asthma with Serum IgE Levels and Skin-Test Reactivity to AllergensThe New England Journal of Medicine, 1989
- Delta‐9‐tetrahydrocannabinol inhibits macrophage protein expression in response to bacterial immunomodulatorsJournal of Toxicology and Environmental Health, 1989
- Inhibition of natural killer cell function by Marijuana componentsJournal of Toxicology and Environmental Health, 1987
- Review of Cannabinoids and their Antiemetic EffectivenessDrugs, 1983
- Cannabinoid induced degranulation of rabbit neutrophilsBiochemical and Biophysical Research Communications, 1982
- Isolation, Structure, and Partial Synthesis of an Active Constituent of HashishJournal of the American Chemical Society, 1964